Due to a production error, there was a mistake in the legends for Figures 6–8 as published. The legend of Figure 6 matches the graph of Figure 7, the legend of Figure 7 matches the graph of Figure 8, and the legend of Figure 8 matches the graph of Figure 6. The correct legends appear below. The publisher apologizes for this mistake.
FIGURE 6
FIGURE 7
FIGURE 8
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
decitabine, azacitidine, acute myeloid leukemia, higher-risk myelodysplastic syndrome, network meta-analysis
Citation
Frontiers Production Office (2023) Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis. Front. Pharmacol. 14:1213053. doi: 10.3389/fphar.2023.1213053
Received
27 April 2023
Accepted
27 April 2023
Published
05 May 2023
Approved by
Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.